Product NDC: | 60505-2527 |
Proprietary Name: | Modafinil |
Non Proprietary Name: | modafinil |
Active Ingredient(s): | 200 mg/1 & nbsp; modafinil |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 60505-2527 |
Labeler Name: | Apotex Corp. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077667 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120926 |
Package NDC: | 60505-2527-0 |
Package Description: | 10 BLISTER PACK in 1 BOX, UNIT-DOSE (60505-2527-0) > 10 TABLET in 1 BLISTER PACK |
NDC Code | 60505-2527-0 |
Proprietary Name | Modafinil |
Package Description | 10 BLISTER PACK in 1 BOX, UNIT-DOSE (60505-2527-0) > 10 TABLET in 1 BLISTER PACK |
Product NDC | 60505-2527 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | modafinil |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20120926 |
Marketing Category Name | ANDA |
Labeler Name | Apotex Corp. |
Substance Name | MODAFINIL |
Strength Number | 200 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Central Nervous System Stimulation [PE],Increased Sympathetic Activity [PE],Sympathomimetic-like Agent [EPC] |